RUO supplier
Official company and public batch-document pages reviewed
Deep research review
Oath Research, formerly Oath Peptides, publishes a large public batch index and names Freedom Diagnostics as its laboratory partner. The site also makes U.S. manufacturing and ISO-protocol claims that require separate facility and certification records.
What this review did not check: Facility, manufacturing, and ISO claims remain supplier claims unless supported by primary records.
Active storefront observed
The official Oath Research storefront and batch-results index were accessible on the review date.
The exact operating legal entity was not established.
Findings
Brand Change
The official site states that Oath Peptides is now Oath Research.
Limit: The date and legal mechanics of the change were not disclosed.
Contact Disclosure
The about page publishes 51 West Vaughn Avenue, Suite 205, Gilbert, Arizona as a contact address.
Limit: The address is not established as the manufacturing facility.
Supplier claim
The company says products are made, tested, and shipped in the United States and that synthesis uses ISO-certified protocols.
Limit: No facility identity or ISO certificate was established.
Public Catalog
The catalog and compound-group batch index are publicly browseable.
Limit: Some additional certificates require an account.
Public Batch Index
The results page displayed 208 tested batches, a 99.60% average, and Freedom Diagnostics as laboratory partner on the review date.
Limit: The count and average are supplier-calculated and can change. Some additional documents are account-gated.
Public sample report
A CJC-1295 no DAC and Ipamorelin blend report for lot B0526 and accession 2602180024 reports 5.76 mg CJC-1295, 6.51 mg Ipamorelin, 99.887% purity, and white lyophilized appearance.
Limit: The result applies only to the listed sample.
Named relationships
named-public-laboratory-partner
Limit: The relationship does not independently verify Oath's manufacturing or ISO claims.
Search limits
Limited regulatory search
No exact-name FDA warning letter, recall, or enforcement page surfaced in the limited FDA-site search.
Limit: Search absence is not regulatory clearance.
Company Position
The footer says Oath Research is not a 503A compounding pharmacy or a 503B outsourcing facility.
Limit: This is the company's legal statement, not an agency determination.
No substantive indexed discussion found
No substantive exact-name Reddit thread surfaced for Oath Research or Oath Peptides in the indexed search.
Limit: Search absence is not evidence of reputation.
Open company questions
Observable documentation fields
This measures fields in normalized public records. It does not score product quality, sterility, legal compliance, or suitability.
Normalized batch records
Each row becomes a stacked record on smaller screens. Coverage means the field appears in the source record. It is not a Peptide Report pass or independent reproduction.
| Product | Batch | Laboratory | Date | Methods | Fields present | Record |
|---|---|---|---|---|---|---|
| AOD-9604 5 mg research material | F2026040 | Freedom Diagnostics Testing | May 29, 2026 | HPLC-UV, LC-MS, LAL | identity, purity, net Content, endotoxin | Source report |
| CJC-1295 no DAC and Ipamorelin research blend | B0526 | Freedom Diagnostics Testing | Feb 20, 2026 | HPLC, LC-MS | identity, purity, net Content | Source report |
Observed catalog records
CJC-1295 (with DAC), Ipamorelin
Source recordOath Peptides rebranded as Oath Research. The profile preserves the former name as an alias for regulatory and directory matching.
Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.
These secondary directories helped identify the company. Their rankings and verification labels are not adopted by Peptide Report.